Sharemaestro Newsreel

908 Devices Secures $6M ProtectIR Order From Asia-Pacific Corrections Agency

908 Devices Inc. (Nasdaq: MASS) reported strong second-quarter 2026 financial results, with revenue increasing 23% year-over-year to $16.1 million and adjusted EBITDA loss narrowing by more than half. The company secured a $6 million ProtectIR order from an Asia-Pacific corrections agency and raised the …

Handelsbanken Fonder AB Sells 1,002,628 Shares of Boston Scientific Corporation $BSX

Handelsbanken Fonder AB has reduced its stake in Boston Scientific Corporation (NYSE:BSX) by 38.8%, selling over 1 million shares but retaining 1.58 million shares valued at $67.6 million. Despite this sale, institutional investors hold a significant 89.07% of the company, and analysts maintain a …

Canaccord raises Ceribell stock price target on strong Q2 results

Canaccord increased its price target for Ceribell (NASDAQ:CBLL) to $26 from $25, maintaining a Buy rating, following strong Q2 fiscal 2026 results. The company reported $28.1 million in revenue, a 33% year-over-year increase, and raised its full-year revenue guidance to $114 million-$117 million. Despite …

TELA Bio, Inc. Stock 12‑Month Price Target Cut to $2.1, Implies 126% Upside

TELA Bio, Inc.'s average 12-month stock price target has been lowered from $2.25 to $2.1 by 5 analysts, with individual forecasts ranging from $1 to $3 per share. Despite the cut, the new target implies a potential upside of approximately 126% from the August …

Handelsbanken Fonder AB Sells 444,592 Shares of Abbott Laboratories $ABT

Handelsbanken Fonder AB reduced its stake in Abbott Laboratories by 37.6% in the second quarter, selling 444,592 shares and retaining 736,804 shares valued at approximately $66.9 million. Abbott Laboratories reported strong quarterly results, exceeding analyst expectations with $12.59 billion in revenue and adjusted earnings …

AI Ultrasound And Breast Imaging Expansion Could Be A Game Changer For GE HealthCare (GEHC)

Price to sales ratio of Inspire Medical Systems, Inc. – HAM:2DR

This article focuses on the price to sales ratio of Inspire Medical Systems, Inc. (HAM:2DR) on the Hamburg Stock Exchange. It provides general financial overview information for the company as listed on TradingView.

Alamar Biosciences, Inc. Stock 12‑Month Price Target Raised to $33.4, Implies 19% Upside

Alamar Biosciences, Inc.'s average 12-month price target has been increased from $31.8 to $33.4 by 5 analysts, with forecasts ranging from $31 to $35 per share. This new target implies approximately 19% potential upside based on the August 10 closing price. The consensus rating …

Does Delcath Systems (DCTH) Have the Potential to Rally 42.77% as Wall Street Analysts Expect?

Shares of Delcath Systems, Inc. (DCTH) have recently gained 29.5%, and Wall Street analysts project a further potential upside of 42.8%, with a mean target price of $23.8. While analysts' price targets can be overly optimistic, the agreement among analysts on higher earnings estimates …

Alamar Biosciences, Inc. 2Q 2026: Revenue $29.4M, EPS $(0.22) — 10-Q Summary

Alamar Biosciences, Inc. reported its second-quarter 2026 results, showing revenue of $29.4 million, an 82% increase year-over-year, driven by a surge in consumables sales. Despite this growth, the company recorded a net loss of $13.2 million and a diluted loss per share of $(0.22). …

Sapient Capital LLC Grows Stake in Stryker Corporation $SYK

Sapient Capital LLC significantly increased its stake in Stryker Corporation (NYSE:SYK) by 168.6% in the second quarter, now holding 6,044 shares valued at $1.9 million. This comes as Stryker reported strong quarterly earnings, beating estimates with $3.69 EPS and a 9.4% revenue increase to …

INSULET CLASS ACTION LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Insulet Corporation and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. has announced the filing of a class action lawsuit against Insulet Corporation (NASDAQ: PODD). The lawsuit, filed in the U.S. District Court for the District of Massachusetts, alleges that Insulet made materially false and misleading statements regarding its manufacturing …

Janus Henderson Group PLC Sells 548,880 Shares of Inspire Medical Systems, Inc. $INSP

Pulsed Field Ablation Global Market Report 2026 Now Available - Profiles Boston Scientific, Medtronic, Biosense Webster, and 15 Other Players

Company Logo Pulsed Field Ablation MarketPulsed Field Ablation Market Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Area, Source of Ablation, Key Geographical Regions, and Sales Forecast of Leading Players - Trends and Forecast …

Insulet Corporation (NASDAQ:PODD) Given Average Rating of "Hold" by Brokerages

Insulet Corporation (NASDAQ:PODD) has received a consensus "Hold" rating from brokerages, with an average 12-month price target of $195.40 despite several firms reducing their targets. The company exceeded quarterly expectations with $1.66 EPS and $801.7 million in revenue, but a reduced fiscal 2026 revenue …

Adapthealth director Kenneth Samet buys $149,930 in shares

AdaptHealth Corp. director Kenneth Samet recently purchased 23,500 shares of company stock for $149,930, bringing his total holdings to 48,569 shares. This insider purchase occurs while AHCO stock is trading near its 52-week low, with InvestingPro analysis suggesting it is undervalued. The company recently …

Non-Viral Transfection Reagents Market Report (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User & Region, Featuring Bio-Rad, MaxCyte, MilliporeSigma, Thermo Fisher Scientific

Company Logo Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents Market (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User and Geographical Regions-Trends and Forecast Till 2035" has been added to ResearchAndMarkets.com's offering. The global non-viral transfection reagents market …

iRhythm Technologies $IRTC Shares Acquired by Quantinno Capital Management LP

Quantinno Capital Management LP significantly increased its stake in iRhythm Technologies (NASDAQ:IRTC) by 1,172.8% in the first quarter, now owning 18,621 shares valued at approximately $2.2 million. The company reported strong financial results, with quarterly revenue up 20.1% year over year to $224.17 million …

Abbott Laboratories (ABT) Just Gave Investors Something To Think About

Abbott Laboratories (ABT) recently exceeded quarterly estimates and increased its annual profit forecast, driven by strong performance in cancer diagnostics and medical devices. The company's stock has shown a significant short-term rebound, up 28.77% over 90 days, despite being down over the past year. …

Renaissance Technologies LLC Takes $2.44 Million Position in Haemonetics Corporation $HAE

Renaissance Technologies LLC has acquired a new position in Haemonetics Corporation, purchasing 43,200 shares valued at approximately $2.44 million. Haemonetics maintains a "Moderate Buy" consensus rating from analysts, with an average price target of $90.89, following strong quarterly earnings that surpassed expectations. Institutional investors …

29,000 Shares in Edwards Lifesciences Corporation $EW Bought by Renaissance Technologies LLC

Renaissance Technologies LLC has acquired 29,000 shares of Edwards Lifesciences Corporation (NYSE:EW) valued at $2.32 million during the first quarter. Institutional investors now hold 79.46% of the company's stock, and analysts maintain a "Moderate Buy" consensus with an average price target of $100.27. Edwards …

E. Ohman J or Asset Management AB Has $7.62 Million Position in DexCom, Inc. $DXCM

E. Ohman J or Asset Management AB increased its stake in DexCom, Inc. by 18.9% in the second quarter, bringing its total holdings to 113,204 shares valued at $7.62 million. Other institutional investors also adjusted their positions in the medical device company. Insider activity …

Intelligent Bio Solutions Completes Method Comparison Study for the Intelligent Fingerprinting Drug Screening System

Intelligent Bio Solutions has completed a multi-site Method Comparison Study for its Intelligent Fingerprinting Drug Screening System, a crucial step for its FDA 510(k) submission to detect codeine in the U.S. market. The study involved 135 participants across three clinical sites and evaluated the …

The Technical Signals Behind (IRTC) That Institutions Follow

This article provides a technical analysis of Irhythm Technologies Inc. (NASDAQ: IRTC), detailing institutional trading strategies based on AI models. It identifies strong near- and mid-term sentiment but a weak long-term outlook, with key support and resistance levels. The analysis also highlights a significant …

Royal Philips And Exor Update Long-Term Relationship Agreement

(RTTNews) - Royal Philips (PHG), a health technology company, and Exor N.V., an investment company, announced that they have agreed to update their long-term relationship agreement. Royal Philips provides image-guided therapy, diagnostic imaging, ultrasound, monitoring, and enterprise informatics and made approximately 18 billion euros …

Exor’s Philips Stake Cap Rises to 22%, but Board Role Is Unchanged

Philips and Exor have updated their long-term relationship agreement, increasing Exor's potential shareholding in Philips from 20% to 22% of issued ordinary share capital and voting rights. Any stake above 22% will require approval from Philips’ Supervisory Board. The governance arrangements, including Exor’s right …

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Reduce" by Analysts

Analysts have issued a consensus "Reduce" rating for Treace Medical Concepts, Inc. (NASDAQ:TMCI), with an average 12-month price target of $5.17, despite the company beating recent quarterly revenue and EPS estimates. The stock opened at $4.67, and significant insider and institutional ownership is noted. …

24,967 Shares in Medtronic PLC $MDT Acquired by First Bank & Trust

First Bank & Trust recently acquired 24,967 shares of Medtronic PLC (NYSE: MDT), valued at approximately $1.95 million. This purchase is part of a trend of institutional investment, as 82.06% of Medtronic's stock is held by institutional investors. Analysts generally maintain a "Moderate Buy" …

Quanterix Cuts 2026 Revenue Outlook as Commercial Challenges Delay Cash-Flow Break-Even

Quanterix has lowered its 2026 revenue forecast and pushed its cash-flow break-even target to 2027 due to weaker-than-expected commercial performance and execution challenges. The company reported 34% revenue growth in Q2 2026 but reduced its full-year outlook by $21-$27 million and expects year-end cash …

Varex Imaging Corporation Stock 12‑Month Price Target Cut to $17.58, Implies 42% Upside

The average 12-month price target for Varex Imaging Corporation (VREX) stock has been lowered from $18 to $17.58 by 5 analysts, with individual forecasts ranging from $12 to $20 per share. This new target suggests a potential upside of approximately 42% from its August …

Establishment Labs Holdings Inc. $ESTA Shares Bought by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly increased its stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 164.9% in the second quarter, now owning 135,897 shares valued at $11.66 million. Other institutional investors also adjusted their positions in the company. Establishment Labs' stock opened at $75.06, …

First Trust Advisors LP Invests $1.03 Million in NovoCure Limited $NVCR

First Trust Advisors LP has invested $1.03 million in NovoCure Limited by acquiring 94,293 shares. Institutional investors collectively own 84.61% of the company, and NovoCure recently reported strong quarterly revenue and a better-than-expected adjusted loss. Analysts currently maintain a "Hold" rating for the stock …

Insulet Corporation $PODD Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly reduced its stake in Insulet Corporation (NASDAQ:PODD) by 67.2% in the second quarter of 2026, selling 173,086 shares and retaining 84,633 shares valued at approximately $12.9 million. This reduction comes despite Insulet exceeding second-quarter expectations with strong EPS and …

PODD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Insulet Corporation Investors Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Insulet Corporation (NASDAQ: PODD) and its officers for alleged violations of federal securities laws. The lawsuit claims that Insulet made materially false and misleading statements regarding defective manufacturing controls and procedures, creating …

Assenagon Asset Management S.A. Has $15.20 Million Stock Position in Glaukos Corporation $GKOS

Assenagon Asset Management S.A. significantly increased its stake in Glaukos Corporation (NYSE:GKOS) by 932.5% in the second quarter, now holding 108,736 shares valued at approximately $15.2 million. Glaukos reported strong Q2 earnings with a 49.6% revenue increase year-over-year and beat analyst EPS expectations, though …

Assenagon Asset Management S.A. Has $16.10 Million Stake in STERIS plc $STE

Assenagon Asset Management S.A. significantly increased its stake in STERIS plc by 56.5% during the second quarter, now holding 76,440 shares valued at $16.10 million. Institutional investors collectively own 94.69% of STERIS, which recently exceeded earnings expectations with $2.59 EPS and $1.49 billion in …